Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Return-On-Investment Report Will Be Subject Of Senate Hearing This Fall

Executive Summary

The Senate Commerce/Science Subcommittee will hold hearings this fall on the return to taxpayers from research funded by the National Institutes of Health.
Advertisement

Related Content

Closing The Books On Taxol: GAO Report Fuels Sen. Wyden’s Pricing Push
Closing The Books On Taxol: GAO Report Fuels Sen. Wyden’s Pricing Push
NIH-funded research
NIH-funded research
"Reasonable pricing" clause
House Medicare Rx Bill Could Be Ready For Floor Vote In October
PhRMA Profitability Defense Cites Ratio Of Taxes To Revenues
NIH Royalty Plan Due March 31 Under Wyden Amendment To Funding Bill
NIH Royalty Plan Due March 31 Under Wyden Amendment To Funding Bill
Amgen Epogen Profit Margins Could Rise 1% After Columbia Patent Expires
Advertisement
UsernamePublicRestriction

Register

PS038408

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel